Effect of zinc supplementation on insulin secretion: interaction between zinc and SLC30A8 genotype in Old Order Amish

Diabetologia

Volumn 58, Issue 2, 2015, Pages 295-303

  Maruthur, Nisa M ^a,b,c   Clark, Jeanne M ^a,b,c   Fu, Mao ^d   Linda Kao, W H ^a,b,c   Shuldiner, Alan R ^d,e  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^e BALTIMORE VA MEDICAL CENTER   (United States)

Author keywords

Insulin secretion; Pharmacogenetic; SLC30A8; Type 2 diabetes; Zinc

Indexed keywords

GLUCOSE; INSULIN; PROINSULIN; SLC30A8 PROTEIN; UNCLASSIFIED DRUG; ZINC ACETATE; ZINC TRANSPORTER; CATION TRANSPORT PROTEIN; SLC30A8 PROTEIN, HUMAN;

ADULT; AGED; AMISH; ARTICLE; CLINICAL TRIAL; FEMALE; GENOTYPE; GLUCOSE TOLERANCE TEST; HOMOZYGOTE; HUMAN; HUMAN EXPERIMENT; INSULIN RELEASE; INSULIN RESPONSE; MALE; NORMAL HUMAN; PHARMACOGENETICS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SUPPLEMENTATION; AREA UNDER THE CURVE; BLOOD; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENT; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; INSULIN RESISTANCE; METABOLISM; MIDDLE AGED; PROSPECTIVE STUDY; TREATMENT OUTCOME; UNITED STATES;

ADULT; AMISH; AREA UNDER CURVE; CATION TRANSPORT PROTEINS; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROINSULIN; PROSPECTIVE STUDIES; TREATMENT OUTCOME; UNITED STATES; ZINC ACETATE;

EID: 84922093330     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-014-3419-1     Document Type: Article

References (50)

1. Diabetes Prevention Program Research Group (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393–403
2. Jablonski KA, McAteer JB, de Bakker PIW et al (2010) Common variants in 40 genes assessed for diabetes incidence and response to metformin and lifestyle intervention in the diabetes prevention program. Diabetes 59:2672–2681
3. Andrulionyte L, Zacharova J, Chiasson JL, Laakso M (2004) Common polymorphisms of the PPAR-gamma2 (Pro12Ala) and PGC-1alpha (Gly482Ser) genes are associated with the conversion from impaired glucose tolerance to type 2 diabetes in the STOP-NIDDM trial. Diabetologia 47:2176–2184
4. Zacharova J, Todorova BR, Chiasson JL, Laakso M (2005) The G-250A substitution in the promoter region of the hepatic lipase gene is associated with the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial. J Intern Med 257:185–193
5. Pearson ER, Donnelly LA, Kimber C et al (2007) Variation in TCF7L2 influences therapeutic response to sulfonylureas: a GoDARTS study. Diabetes 56:2178–2182
6. Zhou K, Bellenguez C, Spencer CC et al (2011) Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes. Nat Genet 43:117–120
7. Zhou K, Donnelly LA, Kimber CH et al (2009) Reduced-function SLC22A1 polymorphisms encoding organic cation transporter 1 and glycemic response to metformin: a GoDARTS study. Diabetes 58:1434–1439
8. Meigs JB, Shrader P, Sullivan LM et al (2008) Genotype score in addition to common risk factors for prediction of type 2 diabetes. N Engl J Med 359:2208–2219
9. Lyssenko V, Jonsson A, Almgren P et al (2008) Clinical risk factors, DNA variants, and the development of type 2 diabetes. N Engl J Med 359:2220–2232
10. Schmid R, Vollenweider P, Bastardot F, Vaucher J, Waeber G, Marques-Vidal P (2012) Current genetic data do not improve the prediction of type 2 diabetes mellitus: the Colaus Study. J Clin Endocrinol Metab 97:E1338–E1341
11. Jing YL, Sun QM, Bi Y, Shen SM, Zhu DL (2011) SLC30A8 polymorphism and type 2 diabetes risk: evidence from 27 study groups. Nutr Metab Cardiovasc Dis 21:398–405
12. Cauchi S, del Guerra S, Choquet H et al (2010) Meta-analysis and functional effects of the SlC30A8 rs13266634 polymorphism on isolated human pancreatic islets. Mol Genet Metab 100:77–82
13. Sladek R, Rocheleau G, Rung J et al (2007) A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 445:881–885
14. Scott LJ, Mohlke KL, Bonnycastle LL et al (2007) A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science (New York, NY) 316:1341–1345
15. Saxena R, Voight BF, Lyssenko V et al (2007) Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 316:1331–1336
16. Takeuchi F, Serizawa M, Yamamoto K et al (2009) Confirmation of multiple risk loci and genetic impacts by a genome-wide association study of type 2 diabetes in the Japanese population. Diabetes 58:1690–1699
17. Chimienti F, Devergnas S, Favier A, Seve M (2004) Identification and cloning of a beta-cell-specific zinc transporter, ZnT-8, localized into insulin secretory granules. Diabetes 53:2330–2337
18. Dunn MF (2005) Zinc-ligand interactions modulate assembly and stability of the insulin hexamer—a review. Biometals 18:295–303
19. Hou JC, Min L, Pessin JE (2009) Insulin granule biogenesis, trafficking and exocytosis. Vitam Horm 80:473–506
20. Boesgaard TW, Zilinskaite J, Vanttinen M et al (2008) The common SLC30A8 Arg325Trp variant is associated with reduced first-phase insulin release in 846 non-diabetic offspring of type 2 diabetes patients—the EUGENE2 study. Diabetologia 51:816–820
21. Majithia A, Jablonski K, McAteer J et al (2011) Association of the SLC30A8 missense polymorphism R325W with proinsulin levels at baseline and after lifestyle, metformin or troglitazone intervention in the Diabetes Prevention Program. Diabetologia 54:2570–2574
22. Stancakova A, Kuulasmaa T, Paananen J et al (2009) Association of 18 confirmed susceptibility loci for type 2 diabetes with indices of insulin release, proinsulin conversion, and insulin sensitivity in 5,327 nondiabetic Finnish men. Diabetes 58:2129–2136
23. Kirchhoff K, Machicao F, Haupt A et al (2008) Polymorphisms in the TCF7L2, CDKAL1 and SLC30A8 genes are associated with impaired proinsulin conversion. Diabetologia 51:597–601
24. Steinthorsdottir V, Thorleifsson G, Reynisdottir I et al (2007) A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nat Genet 39:770–775
25. Tamaki M, Fujitani Y, Hara A et al (2013) The diabetes-susceptible gene SLC30A8/ZnT8 regulates hepatic insulin clearance. J Clin Invest 123:4513–4524
26. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130:461–470
27. Hsueh WC, Mitchell BD, Aburomia R et al (2000) Diabetes in the Old Order Amish: characterization and heritability analysis of the Amish Family Diabetes Study. Diabetes Care 23:595–601
28. Office of Dietary Supplements of the National Institutes of Health (2013) Dietary supplement fact sheet: zinc. Available from http://ods.od.nih.gov/FactSheets/Zinc_pf.asp, Accessed 7 July 2014
29. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419
30. Kazi TG, Afridi HI, Kazi N et al (2008) Copper, chromium, manganese, iron, nickel, and zinc levels in biological samples of diabetes mellitus patients. Biol Trace Elem Res 122:1–18
31. Yerlikaya FH, Toker A, Aribas A (2013) Serum trace elements in obese women with or without diabetes. Indian J Med Res 137:339–345
32. Sun Q, van Dam RM, Willett WC, Hu FB (2009) Prospective study of zinc intake and risk of type 2 diabetes in women. Diabetes Care 32:629–634
33. Capdor J, Foster M, Petocz P, Samman S (2013) Zinc and glycemic control: a meta-analysis of randomised placebo controlled supplementation trials in humans. J Trace Elem Med Biol: Organ Soc Miner Trace Elem 27:137–142
34. Jayawardena R, Ranasinghe P, Galappatthy P, Malkanthi R, Constantine G, Katulanda P (2012) Effects of zinc supplementation on diabetes mellitus: a systematic review and meta-analysis. Diabetol Metab Syndr 4:13
35. Shan Z, Bao W, Zhang Y et al (2014) Interactions between zinc transporter-8 gene (SLC30A8) and plasma zinc concentrations for impaired glucose regulation and type 2 diabetes. Diabetes 63:1796–1803
36. Porter RS (ed) (2011) The Merck manual of diagnosis and therapy. Merck Sharp & Dohme, Whitehouse Station
37. Xu J, Zhou Q, Liu G, Tan Y, Cai L (2013) Analysis of serum and urinal copper and zinc in Chinese northeast population with the prediabetes or diabetes with and without complications. Oxidative Med Cell Longev 2013:635214
38. Hotz C, Peerson JM, Brown KH (2003) Suggested lower cutoffs of serum zinc concentrations for assessing zinc status: reanalysis of the Second National Health and Nutrition Examination Survey data (1976-1980). Am J Clin Nutr 78:756–764
39. Patel C, Chen R, Kodama K, Ioannidis JA, Butte A (2013) Systematic identification of interaction effects between genome- and environment-wide associations in type 2 diabetes mellitus. Hum Genet 132:495–508
40. Kanoni S, Nettleton JA, Hivert M-F et al (2011) Total zinc intake may modify the glucose-raising effect of a zinc transporter (SLC30A8) variant. Diabetes 60:2407–2416
41. Nicolson TJ, Bellomo EA, Wijesekara N et al (2009) Insulin storage and glucose homeostasis in mice null for the granule zinc transporter ZnT8 and studies of the type 2 diabetes-associated variants. Diabetes 58:2070–2083
42. Lemaire K, Ravier MA, Schraenen A et al (2009) Insulin crystallization depends on zinc transporter ZnT8 expression, but is not required for normal glucose homeostasis in mice. Proc Natl Acad Sci U S A 106:14872–14877
43. Wijesekara N, Dai FF, Hardy AB et al (2010) Beta cell-specific ZnT8 deletion in mice causes marked defects in insulin processing, crystallisation and secretion. Diabetologia 53:1656–1668
44. Fu Y, Tian W, Pratt EB et al (2009) Down-regulation of ZnT8 expression in INS-1 rat pancreatic beta cells reduces insulin content and glucose-inducible insulin secretion. PLoS One 4:e5679
45. Chimienti F, Devergnas S, Pattou F et al (2006) In vivo expression and functional characterization of the zinc transporter ZnT8 in glucose-induced insulin secretion. J Cell Sci 119:4199–4206
46. Pound LD, Sarkar SA, Benninger RK et al (2009) Deletion of the mouse Slc30a8 gene encoding zinc transporter-8 results in impaired insulin secretion. Biochem J 421:371–376
47. Pound LD, Sarkar SA, Cauchi S et al (2011) Characterization of the human SLC30A8 promoter and intronic enhancer. J Mol Endocrinol 47:251–259
48. Flannick J, Thorleifsson G, Beer NL et al (2014) Loss-of-function mutations in SLC30A8 protect against type 2 diabetes. Nat Genet 46:357–363
49. Kim I, Kang ES, Yim YS et al (2011) A low-risk ZnT-8 allele (W325) for post-transplantation diabetes mellitus is protective against cyclosporin A-induced impairment of insulin secretion. Pharmacogenomics J 11:191–198
50. Weijers RN (2010) Three-dimensional structure of beta-cell-specific zinc transporter, ZnT-8, predicted from the type 2 diabetes-associated gene variant SLC30A8 R325W. Diabetol Metab Syndr 2:33